Edison Histotripsy System

Robotic, image-guided focused ultrasound (histotripsy) platform that mechanically destroys and liquefies targeted tumors non-invasively without incisions. Uses a robotic arm to deliver focused ultrasound energy. First and only histotripsy platform cleared for clinical use globally.

Yes. Edison Histotripsy System is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.

Edison Histotripsy System is made by HistoSonics, based in Plymouth, MN, USA, founded in 2009.

14 verified deployments of Edison Histotripsy System are on the DEPLOY registry, including at Cambridge University Hospital, Banner Gateway Medical Center, Miami, Florida, USA.

Edison Histotripsy System is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.

On the DEPLOY registry, comparable surgical robots to Edison Histotripsy System include da Vinci (and Ion), Edge Multi-Port Surgical Robot, Stryker Mako SmartRobotics, Toumai.

Edison Histotripsy System and da Vinci (and Ion) (Intuitive Surgical · 15 deployments) are both surgical robots on the DEPLOY registry. Edison Histotripsy System has 14 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Edison Histotripsy System ranks in roughly the top 2% of surgical models tracked by the registry.

Edison Histotripsy System is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.

Edison Histotripsy System has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.